+852 3460 3857

體外反搏治療顯著改善多項心肺運動測試數值,及提升運動耐力

EECP significantly improved the Exercise Endurance of Low Endurance Adults, and COPD Patients

Source From 資料來源 : https://pubmed.ncbi.nlm.nih.gov/32021141/

 

EECP significantly improved the Exercise Endurance of Low Endurance Adults, and COPD Patients

PURPOSE:

Enhanced external counterpulsation (EECP) is popular in China for the treatment of coronary heart diseases, but it may be an effective treatment for other populations. This study aimed to explore the effect of EECP on exercise endurance of healthy people and chronic obstructive pulmonary disease (COPD) patients and provide intervention measures to improve their physical condition.

PATIENTS AND METHODS:

Patients were enrolled in this pilot randomized controlled trial at Jiangbin Hospital, China, between March 1st and May 30th, 2018. They were randomly divided into the EECP and non-EECP groups. According to their maximal oxygen uptake, the volunteers were also sub-grouped into the normal, low exercise endurance, and COPD subgroups. Differences in exercise endurance were evaluated between the EECP and non-EECP groups before and after treatment.

Cardiopulmonary exercise testng included anaerobic threshold oxygen uptake (AT-VO2Kg), maximum oxygen uptake (Max-VO2Kg), anaerobic threshold pulse (AT-O2puls), anaerobic threshold metabolic equivalent (AT-Mets), and maximum metabolic equivalent (Max-Mets).

RESULTS:

72 volunteers were enrolled. The EECP and non-EECP groups were similar in terms of age, sex, body mass index, blood pressure, heart rate, breathing frequency, AT-VO2Kg, Max-VO2Kg, AT-O2puls, AT-Mets, and Max-Mets (P > 0.05) before treatment. EECP significantly improved AT-VO2Kg, Max-VO2Kg, AT-O2puls, AT-Mets, and Max-Mets compared with the non-EECP group (P<0.05). When analyzed according to sub-groups, the AT-VO2Kg, Max-VO2Kg, AT-O2puls, AT-Mets, and Max-Mets of the normal, low exercise endurance, and COPD subgroups were all significantly increased after EECP (P<0.05).

CONCLUSION:

EECP significantly improved the exercise endurance of normal adults, low endurance adults, and COPD patients.

 

「增強體外反搏對慢性阻塞性肺病患者和健康受試者 運動耐力 的療效: 試點隨機臨床試驗」

目的

體外反搏治療(EECP)在中國用於冠狀動脈心臟病的治療相當普遍,但它也可能對其他人群有效。本研究旨在探討體外反搏治療對健康人和慢性阻塞性肺疾病(COPD)患者的 運動耐力 的影響,並提供改善其身體狀況的干預措施。

患者和方法

中國江濱醫院進行了一項隨機對照試驗,參與者被隨機分為體外反搏治療組和非體外反搏治療組。志願者被分為正常、低 運動耐力 和慢性阻塞性肺疾病亞組。比較體外反搏治療組和非體外反搏治療組在治療前後的 運動耐力 差異。心肺運動測試包括無氧閾值氧耗量、最大氧耗量、無氧閾值脈搏、無氧閾值代謝當量和最大代謝量。

結果

體外反搏治療組和非體外反搏治療組在年齡、性別、體重指數、血壓、心率、呼吸頻率、等方面在治療前是相似的。與非體外反搏治療組相比,體外反搏治療顯著改善了多項心肺運動測試數值。另外,亞組的數值也同樣得到顯著增加

結論

EECP顯著改善了正常成年人、低耐力成年人和COPD患者的 運動耐力 。

WhatsApp chat